Earnings call transcript: Starling Oncology Q2 2026 revenue tops forecast, stock jumps — See source for full details.
$STLN
Price history, market instrument context, member research, and related headlines in one place.
STLN key statistics
NasdaqCMUSD
52-week range
$2.3291%$7.13
Latest session $6.66–$6.95The Oncology Institute, Inc. (STLN) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $6.71, down $0.20 (2.89%) from the previous close of $6.91. It has traded between $6.66 and $6.95 in the latest session. Over the past year it has ranged from $2.32 to $7.13, leaving it in the upper quarter of its 52-week range (91%). Reported volume for the session was 1.1M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
WOOK AIASK ANYTHING · NEVER ADVISES
Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.
Source-linked intelligence
Related news
Loading $STLN research…